Trial Profile
A trial to investigate whether vardenafil, a phosphodiesterase-5 inhibitor, alters plasma levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and arginine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2016
Price :
$35
*
At a glance
- Drugs Vardenafil (Primary) ; Arginine
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- 20 Jul 2016 New trial record